BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Liu Z, Wu D, Chen L, Xie L. Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis. Front Oncol 2020;10:596318. [PMID: 33224891 DOI: 10.3389/fonc.2020.596318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye B, Shen Y, Chen H, Lin S, Mao W, Dong Y, Li X. Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease. Sci Rep 2022;12:14428. [PMID: 36002595 DOI: 10.1038/s41598-022-13272-4] [Reference Citation Analysis]
2 Marsh-Wakefield F, Ferguson AL, Liu K, Santhakumar C, McCaughan G, Palendira U. Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma. Ther Adv Med Oncol 2022;14:17588359221113270. [PMID: 35898965 DOI: 10.1177/17588359221113270] [Reference Citation Analysis]
3 Mattos ÂZ, Debes JD, Vogel A, Arrese M, Revelo X, Pase THS, Manica M, Mattos AA. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy? . World J Gastroenterol 2022; 28(28): 3595-3607 [DOI: 10.3748/wjg.v28.i28.3595] [Reference Citation Analysis]
4 Liu Y, Zhang L, Ju X, Wang S, Qie J. Single-Cell Transcriptomic Analysis Reveals Macrophage–Tumor Crosstalk in Hepatocellular Carcinoma. Front Immunol 2022;13:955390. [DOI: 10.3389/fimmu.2022.955390] [Reference Citation Analysis]
5 Ding F, Li J, Zhang Y, Wang C, Yu Y, Isaguliants M. Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/8248355] [Reference Citation Analysis]
6 Zanotti S, Boot GF, Coto-llerena M, Gallon J, Hess GF, Soysal SD, Kollmar O, Ng CKY, Piscuoglio S. The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective. Front Med 2022;9:888850. [DOI: 10.3389/fmed.2022.888850] [Reference Citation Analysis]
7 Liu Z, Zhang S, Ouyang J, Wu D, Chen L, Zhou W, Xie L, Zhang Y. Single-Cell RNA-seq Analysis Reveals Dysregulated Cell-Cell Interactions in a Tumor Microenvironment Related to HCC Development. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/4971621] [Reference Citation Analysis]
8 Laumont CM, Banville AC, Gilardi M, Hollern DP, Nelson BH. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev Cancer 2022. [PMID: 35393541 DOI: 10.1038/s41568-022-00466-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
9 Liu J, Gu L, Zhang D, Li W. Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients. Front Mol Biosci 2022;9:759792. [DOI: 10.3389/fmolb.2022.759792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Qin Z, Luo K, Liu Y, Liao S, He J, He M, Xie T, Jiang X, Li B, Liu H, Huang Q, Tang H, Feng W, Zhan X. ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing. IJGM 2022;Volume 15:1033-45. [DOI: 10.2147/ijgm.s341879] [Reference Citation Analysis]
11 Lu J, Chen Y, Zhang X, Guo J, Xu K, Li L. A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02469-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Huang RH, Wang LX, He J, Gao W. Application and prospects of single cell sequencing in tumors. Biomark Res 2021;9:88. [PMID: 34895349 DOI: 10.1186/s40364-021-00336-2] [Reference Citation Analysis]
13 Han Q, Deng H, Fan X, Wang X, Zhang X, Zhang K, Li N, Lv Y, Liu Z. Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1367-73. [PMID: 34805015 DOI: 10.2147/JHC.S337936] [Reference Citation Analysis]
14 Rong MH, Li JD, Zhong LY, Huang YZ, Chen J, Xie LY, Qin RX, He XL, Zhu ZH, Huang SN, Zhou XG. CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle. Exp Biol Med (Maywood) 2021;:15353702211049149. [PMID: 34743578 DOI: 10.1177/15353702211049149] [Reference Citation Analysis]
15 Zhao Y, Zhang J, Wang S, Jiang Q, Xu K. Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC. Front Cell Dev Biol 2021;9:731790. [PMID: 34557495 DOI: 10.3389/fcell.2021.731790] [Reference Citation Analysis]
16 Feng W, He M, Jiang X, Liu H, Xie T, Qin Z, Huang Q, Liao S, Lin C, He J, Xu J, Ma J, Liu Y, Wei Q. Single-Cell RNA Sequencing Reveals the Migration of Osteoclasts in Giant Cell Tumor of Bone. Front Oncol 2021;11:715552. [PMID: 34504794 DOI: 10.3389/fonc.2021.715552] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Brochado-Kith Ó, Martínez I, Berenguer J, González-García J, Salgüero S, Sepúlveda-Crespo D, Díez C, Hontañón V, Ibañez-Samaniego L, Pérez-Latorre L, Fernández-Rodríguez A, Ángeles Jiménez-Sousa M, Resino S. HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients. Front Immunol 2021;12:723196. [PMID: 34497613 DOI: 10.3389/fimmu.2021.723196] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen L, Yang Z, Cao Y, Hu Y, Bao W, Wu D, Hu L, Xie J, Yu H. Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma. Channels (Austin) 2021;15:541-54. [PMID: 34494510 DOI: 10.1080/19336950.2021.1968592] [Reference Citation Analysis]
19 Ding LH, Yu Y, Edmondson EF, Weil MM, Pop LM, McCarthy M, Ullrich RL, Story MD. Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes. Sci Rep 2021;11:14052. [PMID: 34234215 DOI: 10.1038/s41598-021-93467-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Liu J, Zhang SQ, Chen J, Li ZB, Chen JX, Lu QQ, Han YS, Dai W, Xie C, Li JC. Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients. J Oncol 2021;2021:5574150. [PMID: 34257652 DOI: 10.1155/2021/5574150] [Reference Citation Analysis]